Board certified AP/CP pathologist with GI and Liver pathology fellowship training; Focused on epidemiology and biology of breast and colorectal cancers, and economics of public healthcare systems; Editorial board membership of 10 peer-reviewed journals; Outstanding reviewer awards, Gastroinst Endosc; (Co-)directorship for more than 10 CME programs; Fellowship, ACG and CAP.
I pursued my bioinformatics Ph.D. degree in the center of bioinformatics in Peking University. During my Ph.D. study, I received comprehensive training in molecular biology, biostatistics and bioinformatics including research designs, computational tool development and database implementation. With a solid background and comprehensive knowledge in bioinformatics and biological networks, I filled a postdoctoral research fellow position at the Vanderbilt University. During this period, I received excellent training in the understanding of genetics of complex diseases including cancer and pulmonary disease, and I applied my bioinformatics skills in analysis of large scale next-generation sequencing (NGS) data.
To date, I have worked in four different research areas. The first is data collection from public literature and databases to build bioinformatics tools for public use. The second is the integrative analysis of NGS data to decipher the genetic mechanism of complex disease. Thirdly, I applied network-based strategy on the interplay of tumor suppressor genes (TSGs) and oncogenes (OCGs) using the public cancer genomic/epigenetic data. Lastly, I translated my disease genomics expertise to huge marine genomic data to explore the common cell-cell communication mechanisms of metazoan.
Shengtao Zhou is currently a professor in Department of Obstetrics and Gynecology, West China Second Hospital and in Department of Proteomics and Mass Spectrometry, National Key Laboratory of Biotherapy, Sichuan University. He is a member of American Association for Cancer Research, Human Proteome Organization, American Society for Mass Spectrometry and American Society for Biochemistry and Molecular Biology. He also serves on the Editorial Board of Mass Spectrometry Reviews, Cancer Letters and PLOS ONE.
Professor emeritus of the University of Freiburg and the University of Heidelberg & the past Scientific Director of the German Cancer Research Center in Heidelberg. Awards include the Robert-Koch-Price; the Charles S. Mott Prize; the Paul-Ehrlich-Ludwig Darmstätter-Price; & the 2008 Nobel-Prize for Medicine. Past Editor in Chief of the International Journal of Cancer and former member of the Board of Directors of the International Union against Cancer (UICC).